AZN - Spark Newswire

2 minute read

Fixed-Dose Combination of Albuterol and Budesonide Demonstrated Significant Benefits for Asthma Patients in MANDALA and DENALI Phase III Trials

By Benzinga Newsdesk

Today, 1:21 PM

AZN

1 minute read

AstraZeneca’s Two Asthma Trials Meet Primary Endpoints

By Vandana Singh

Today, 1:21 PM

Avillion LLP announces positive topline results from the MANDALA and DENALI Phase 3 trials of PT027 in asthma patients. PT027…

AZN

2 minute read

News

AstraZeneca Announced PT027 PhIII Asthma Trials Met Primary Endpoints

By Charles Gross

Today, 1:21 PM

Positive high-level results from the MANDALA and DENALI Phase III trials of PT027 (albuterol/budesonide), at both 180/160mcg and 180/80mcg doses, met all primary endpoints demonstrating statistically significant benefits in patients with asthma versus individual components albuterol, also known as salbutamol (180mcg) and budesonide (160mcg).

AZN

1 minute read

FDA
News

EMA To Add New Side Effects To Janssen, AstraZeneca COVID-19 Shots

By Vandana Singh

Today, 1:21 PM

The European Medicines Agency (EMA) has finalized to update the product information of COVID-19 vaccines developed by Johnson & Johnson (NYSE:JNJ) and AstraZeneca…

AZN

1 minute read

FDA
News

EMA Publishes New Safety Updates For Comirnaty, COVID-19 Vaccine Janssen, SpikeVax And Vaxzevria; Says Pain In Legs, Arms Or Stomach And Influenza-Like Symptoms Have Also Been Included In Product Information As Side Effect Of AstraZeneca Vaccine

By Benzinga Newsdesk

Today, 1:21 PM

-Reuters

AZN

1 minute read

Johnson & Johnson Plans COVID-19 Booster Shot Trial In South Africa: Bloomberg

By Vandana Singh

Today, 1:21 PM

Johnson & Johnson (NYSE:JNJ) is reportedly considering running a COVID-19 vaccine booster trial in South Africa after its jab was used…

AZN

5 minute read

The Daily Biotech Pulse: MacroGenics’ Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA’s FDA Nod

By Shanthi Rexaline

Today, 1:21 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7)

ADIL

1 minute read

HUTCHMED And AstraZeneca Initiate SANOVO Phase III Trial Of ORPATHYS And TAGRISSO Combination As A First-Line Therapy For Certain Lung Cancer Patients in China

By Benzinga Newsdesk

Today, 1:21 PM

HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) and AstraZeneca PLC ("AstraZeneca") (NASDAQ:AZN) have initiated SANOVO, a China Phase III study of ORPATHYS® (savolitinib), an

AZN

1 minute read

Amgen, AstraZeneca Tout Additional Data From Asthma Trial With Tezepelumab

By Vandana Singh

Today, 1:21 PM

Amgen Inc (NASDAQ:AMGN) announced new data from the NAVIGATOR Phase 3 trial evaluating tezepelumab in patients who also have nasal polyps,…

AMGN

1 minute read

Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay

By Vandana Singh

Today, 1:21 PM

Illumina Inc (NASDAQ:ILMN) and Merck & Co Inc (NYSE:MRK) provided more details on their partnership to develop and commercialize tests that gauge genetic…

AZN

Feed Symbols: AZN